(Q44394023)

2 December 2017

Phenotypes of resistance in community urinary tract isolates of Escherichia coli: therapeutic implications (English)

1 reference

2 December 2017

1 reference

Mercedes Alonso Sanz

1

1 reference

PubMed ID

12681098

2 December 2017

M Isabel Abad Bécquer

series ordinal

2

1 reference

PubMed ID

12681098

2 December 2017

language of work or name

Spanish

0 references

publication date

1 March 2003

1 reference

2 December 2017

1 reference

2 December 2017

120

1 reference

2 December 2017

10

1 reference

2 December 2017

361-364

1 reference

Diagnosis and treatment of uncomplicated urinary tract infection

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973705-1

Antibacterial use in community practice: assessing quantity, indications and appropriateness, and relationship to the development of antibacterial resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973705-1

[Characteristics of primary care clinical guidelines associated with greater structural quality of the document]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973705-1

Comparison of E test and double disk diffusion test for detection of extended spectrum beta-lactamases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973705-1

Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973705-1

A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian Urinary Isolate Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973705-1

Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973705-1

Ampicillin-sulbactam and amoxicillin-clavulanate susceptibility testing of Escherichia coli isolates with different beta-lactam resistance phenotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973705-1

Interpretative reading: recognizing the unusual and inferring resistance mechanisms from resistance phenotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973705-1

[Interpretive reading of the antibiogram of enterobacteria].

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973705-1

Extended-spectrum beta-lactamases: frequency, risk factors, and outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973705-1

Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973705-1

Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973705-1

Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973705-1

Fosfomycin: an underrated antibiotic for urinary tract infections due to Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973705-1

[Selection of antibiotic-resistant bacteria: microbiological and pharmacological factors]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973705-1

Mechanisms of action of antimicrobials: focus on fluoroquinolones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973705-1

Detection and reporting of organisms producing extended-spectrum beta-lactamases: survey of laboratories in Connecticut

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973705-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-7753(03)73705-1

1 reference

2 December 2017

1 reference

PubMed ID

12681098